Mirabegron as effective as oxybutynin for ureteral stent symptoms.

OBJECTIVE: Ureteral stents usually cause pain and lower urinary tract discomfort. This study aimed to compare the effect of mirabegron with oxybutynin in relieving ureteral stent-related symptoms over time. METHODS: A prospective, longitudinal, randomized, single-blinded study was conducted. Patients who had a ureteral stent inserted after urolithiasis treatment were classified into two groups and received either oxybutynin 5 mg/day (Group O) or mirabegron 50 mg/day (Group M). The Ureteral Stent Symptoms Questionnaire (USSQ) was applied on the 3rd, 6th, and 15th postoperative days. Group domain scores were compared, and a mixed linear model was used to better assess score differences. RESULTS: Ureteral Stent Symptoms Questionnaire scores were similar in both groups during all three postoperative days (p>0.05). A longitudinal analysis showed that global quality of life and general health improved over time, independently of the use of any of the medications (p<0.05), while urinary symptoms and body pain scores were lower over time in participants receiving oxybutynin. CONCLUSION: Both mirabegron and oxybutynin are equivalent in relieving ureteral stent symptoms. Moreover, some stent symptoms seem to decrease over time despite the use of medication.

Doença de Behçet em adolescente: relato de caso / Behçet's disease in a adolescent: case report

OBJETIVO: Relatar o caso de uma paciente adolescente com diagnóstico de Doença de Behçet e correspondente revisão da literatura. DESCRIÇÃO DO CASO: Paciente de 17 anos apresentando severa mialgia generalizada e com queixa de febre intermitente há 10 dias, com edema de lábios, úlceras e aftas orais. Perda de peso por dificuldade de deglutição pelas dores das lesões orais, incapacidade de deambulação por piora progressiva da mialgia e dores articulares e febre elevada contínua. Apresentou melhora com corticoterapia e recebeu alta com prednisona oral, hidroxicloroquina, cálcio e vitamina D. COMENTÁRIOS: É importante direcionar o tratamento em tempo que evite um desfecho desfavorável por conta de complicações e manifestações mais graves da doença, por meio do diagnóstico precoce associado ao tratamento efetivo e individualizado.

OBJECTIVE: To report the case of an adolescent patient diagnosed with Behçet's Disease and a corresponding literature review. CASE DESCRIPTION: A 17-year-old patient with severe generalized myalgia and complaining of intermittent fever for 10 days, with edema of the lips, ulcers and oral thrush. Weight loss due to difficulty in swallowing due to pain from oral lesions, inability to walk due to progressive worsening of myalgia and joint pain and continuous high fever. She improved with corticosteroid therapy and was discharged with oral prednisone, hydroxychloroquine, calcium and vitamin D. COMMENTS: It is important to direct treatment in time to avoid an unfavorable outcome due to complications and more serious manifestations of the disease, through early diagnosis associated with effective and individualized treatment